Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatrics.
In pediatric practice, nalbuphine hydrochloride can be administered by continuous infusion through a multiport manifold or Y-site connection over 24 h in a 60 mL polypropylene syringe unprotected from light at concentrations ranging from 52.1 µg.mL-1 to 333.3 µg.mL-1 in normal saline (NS). To limit...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Online Access: | https://doi.org/10.1371/journal.pone.0330869 |
